{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "regularMarketChangePercent": -0.4474273, "regularMarketPrice": 2225.0, "exchange": "KOE", "shortName": "ChoA Pharm.", "longName": "ChoA Pharmaceutical Co., LTD.", "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "market": "kr_market", "marketState": "PREPRE", "esgPopulated": false, "sharesOutstanding": 28310200, "fiftyDayAverage": 2216.6, "fiftyDayAverageChange": 8.399902, "fiftyDayAverageChangePercent": 0.0037895434, "twoHundredDayAverage": 2424.675, "twoHundredDayAverageChange": -199.67505, "twoHundredDayAverageChangePercent": -0.08235126, "marketCap": 62990196736, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "prevName": "ChoA Pharmaceutical Co.,Ltd", "nameChangeDate": "2023-05-13", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 968889600000, "priceHint": 2, "regularMarketChange": -10.0, "regularMarketTime": 1683873030, "regularMarketDayHigh": 2250.0, "regularMarketDayRange": "2210.0 - 2250.0", "regularMarketDayLow": 2210.0, "regularMarketVolume": 36494, "regularMarketPreviousClose": 2235.0, "bid": 2220.0, "ask": 2225.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KOSDAQ", "financialCurrency": "KRW", "regularMarketOpen": 2235.0, "averageDailyVolume3Month": 60093, "averageDailyVolume10Day": 46512, "fiftyTwoWeekLowChange": 220.0, "fiftyTwoWeekLowChangePercent": 0.109725684, "fiftyTwoWeekRange": "2005.0 - 4105.0", "fiftyTwoWeekHighChange": -1880.0, "fiftyTwoWeekHighChangePercent": -0.45797807, "fiftyTwoWeekLow": 2005.0, "fiftyTwoWeekHigh": 4105.0, "symbol": "034940.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "ACE Techno-Tower", "address2": "1st Floor 12, Dangsan-ro 2-gil Yeongdeungpo-gu", "city": "Seoul", "zip": "07299", "country": "South Korea", "phone": "82 2 6670 9200", "fax": "82 2 2166 4111", "website": "https://www.choa.co.kr", "industry": "", "sector": "", "longBusinessSummary": "ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers its products in the form of tablets, capsules, granules, syrups, solutions, drinkable ampoules, and sachets. It also provides medicine supply and pharmacy management services. The company exports its products to approximately 20 countries worldwide. ChoA Pharmaceutical Co., Ltd. was founded in 1988 and is headquartered in Seoul, South Korea.", "fullTimeEmployees": 260, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sung-Hwan  Cho", "age": 52, "title": "Chief Exec. Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}